LLY

866.19

+3.49%↑

UNH

516.46

+0.12%↑

JNJ

163.28

-0.06%↓

ABBV

209.03

-0.39%↓

NVO

75.31

-1.89%↓

LLY

866.19

+3.49%↑

UNH

516.46

+0.12%↑

JNJ

163.28

-0.06%↓

ABBV

209.03

-0.39%↓

NVO

75.31

-1.89%↓

LLY

866.19

+3.49%↑

UNH

516.46

+0.12%↑

JNJ

163.28

-0.06%↓

ABBV

209.03

-0.39%↓

NVO

75.31

-1.89%↓

LLY

866.19

+3.49%↑

UNH

516.46

+0.12%↑

JNJ

163.28

-0.06%↓

ABBV

209.03

-0.39%↓

NVO

75.31

-1.89%↓

LLY

866.19

+3.49%↑

UNH

516.46

+0.12%↑

JNJ

163.28

-0.06%↓

ABBV

209.03

-0.39%↓

NVO

75.31

-1.89%↓

Search

10X Genomics Inc (Class A)

Cerrado

SectorSalud

10.41 0.1

Resumen

Variación precio

24h

Actual

Mínimo

10.29

Máximo

10.58

Métricas clave

By Trading Economics

Ingresos

-13M

-49M

Ventas

13M

165M

BPA

-0.136

Margen de beneficio

-29.71

Empleados

1,306

EBITDA

-14M

-38M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+57.46% upside

Dividendos

By Dow Jones

Próximas Ganancias

29 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.3B

Apertura anterior

10.31

Cierre anterior

10.41

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

375 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

10X Genomics Inc (Class A) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

24 mar 2025, 23:47 UTC

Charlas de Mercado

Nikkei May Rise as Concerns About U.S. Tariffs Ease -- Market Talk

24 mar 2025, 23:47 UTC

Charlas de Mercado

Gold Consolidates; May Be Weighed by Easing Worries Over U.S. Tariffs -- Market Talk

24 mar 2025, 23:27 UTC

Ganancias

Zoomlion Heavy Industry Science and Technology: Accelerating Development of New Quality Productive Forces >1157.HK

24 mar 2025, 23:27 UTC

Ganancias

Zoomlion Heavy Industry Science and Technology: Continuously Improving Scientific Research and Innovation >1157.HK

24 mar 2025, 23:25 UTC

Ganancias

Zoomlion Heavy Industry Science and Technology: To Fully Establish Overseas Business System >1157.HK

24 mar 2025, 23:24 UTC

Ganancias

Zoomlion Heavy Industry Science and Technology: Accelerating Development of Industrial Echelons >1157.HK

24 mar 2025, 23:21 UTC

Ganancias

Zoomlion Heavy Industry Science and Technology 2024 Net CNY3.52B Vs. Net CNY3.55B >1157.HK

24 mar 2025, 23:20 UTC

Ganancias

Zoomlion Heavy Industry Science and Technology 2024 Rev CNY45.48B Vs. CNY47.08B >1157.HK

24 mar 2025, 22:08 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

James Hardie's Azek Buy Will Take Some Time to Digest -- Market Talk

24 mar 2025, 22:06 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Gold Fields, Gold Road Relationship Turning Frosty -- Market Talk

24 mar 2025, 21:18 UTC

Principales Noticias

FBI Launches Task Force to Investigate Threats Against Tesla -- Barrons.com

24 mar 2025, 21:03 UTC

Principales Noticias

FBI Launches Task Force to Investigate Threats Against Tesla -- Barrons.com

24 mar 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

24 mar 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

24 mar 2025, 20:42 UTC

Principales Noticias

Boeing Is Pushing to Withdraw Guilty Plea Agreement -- WSJ

24 mar 2025, 20:32 UTC

Ganancias

Boeing Gains and Lockheed Stock Falls Further After Fighter Jet Upset -- Barrons.com

24 mar 2025, 20:32 UTC

Principales Noticias

U.S. Stocks Rally After Latest Twist in Tariff Saga Eases Investors' Worries -- WSJ

24 mar 2025, 20:17 UTC

Principales Noticias

Dow Gains About 600 Points on Tariff Optimism -- WSJ

24 mar 2025, 20:16 UTC

Principales Noticias

FBI Launches Task Force to Investigate Threats Against Tesla -- Barrons.com

24 mar 2025, 20:09 UTC

Charlas de Mercado

Canada Consumer Confidence Hits New Low, Labor Expectations Sour -- Market Talk

24 mar 2025, 19:25 UTC

Charlas de Mercado

U.S. Natural Gas Loses Ground on Mild Weather Outlook -- Market Talk

24 mar 2025, 19:10 UTC

Charlas de Mercado

Oil Gains As Trump Aims at Buyers of Venezuelan Crude -- Market Talk

24 mar 2025, 18:59 UTC

Charlas de Mercado

Gold Backtracks As Investors Stay Cautious -- Market Talk

24 mar 2025, 18:46 UTC

Charlas de Mercado

Telus' Cash Flow From Digital Business Isn't Seen as Impairment -- Market Talk

24 mar 2025, 18:03 UTC

Principales Noticias

Dow Gains About 500 Points on Tariff Optimism -- WSJ

24 mar 2025, 17:57 UTC

Principales Noticias

Fed's Bostic Sees Only One Rate Cut This Year, Down From Prior Forecast Of Two Moves -- MarketWatch

24 mar 2025, 17:50 UTC

Principales Noticias

Trump Says Auto, Pharma Tariffs Coming Soon, but Doesn't Mention April 2 -- WSJ

24 mar 2025, 17:46 UTC

Principales Noticias

BYD Stock Jumps. Car Sales Topped Tesla's for First Time. -- Barrons.com

24 mar 2025, 17:38 UTC

Charlas de Mercado

Small Impact Seen From Venezuelan Crude-Related Tariffs -- Market Talk

24 mar 2025, 17:02 UTC

Ganancias

Affirm Stock Has 'Plenty of Greenfield' Ahead. These Are the Challenges. -- Barrons.com

Comparación entre iguales

Cambio de precio

10X Genomics Inc (Class A) Esperado

Precio Objetivo

By TipRanks

57.46% repunte

Estimación a 12 meses

Media 16.36 USD  57.46%

Máximo 26 USD

Mínimo 12 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para 10X Genomics Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

6

Comprar

6

Mantener

0

Vender

Puntuación técnica

By Trading Central

10.28 / 10.415Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

No Evidence

Sentimiento

By Acuity

375 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.